Last updated on June 2019

Non-Interventional Study on the Tolerability and Efficacy of IVIG


Brief description of study

Non-Interventional Study on the Tolerability and Efficacy of octagam 10%

Detailed Study Description

A Non-Interventional Study on the Tolerability and Efficacy of Octagam 5% or 10% or panzyga. Patients with any indication (replacement and immonomodulation) as prescribed by the treating physician. Marketed Octagam 5% or 10% or panzyga will be used according to the investigator prescription; intravenous (iv) administration.The primary objective is to detect and evaluate adverse drug reactions (ADRs) occurring during or after the administration of Octagam or panzyga in any indication, age group or treatment regimen, where a causal relationship to the administration of Octagam or panzyga is suspected.

Clinical Study Identifier: NCT02303093

Find a site near you

Start Over

St. Paul's Hospital

Vancouver, BC Canada
  Connect »

Octapharma Research Site

Plymouth, United Kingdom
  Connect »

Octapharma Research Site

Stafford, United Kingdom
  Connect »